Page 23 - Read Online

Peng et al. Microbiome Res Rep 2024;3:5 https://dx.doi.org/10.20517/mrr.2023.47 Page 17 of 17

carcinoma. Eur Urol 2022;81:95-103. DOI PubMed
98. Vétizou M, Pitt JM, Daillère R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science
2015;350:1079-84. DOI PubMed PMC
99. Mager LF, Burkhard R, Pett N, et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy.
Science 2020;369:1481-9. DOI
100. Pederzoli F, Bandini M, Raggi D, et al. Is there a detrimental effect of antibiotic therapy in patients with muscle-invasive bladder
cancer treated with neoadjuvant pembrolizumab? Eur Urol 2021;80:319-22. DOI
101. Gopalakrishnan V, Spencer CN, Nezi L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma
patients. Science 2018;359:97-103. DOI PubMed PMC
102. Matson V, Fessler J, Bao R, et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.
Science 2018;359:104-8. DOI PubMed PMC
103. Chen C, Huang Z, Huang P, et al. Urogenital microbiota:potentially important determinant of PD-L1 expression in male patients with
non-muscle invasive bladder cancer. BMC Microbiol 2022;22:7. DOI PubMed PMC
104. Shen X, Zhao B. Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis. BMJ 2018;362:k3529.
DOI PubMed PMC
105. Brausi M, Oddens J, Sylvester R, et al. Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-
risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study
comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG. Eur Urol 2014;65:69-76. DOI PubMed
106. Domingos-Pereira S, Sathiyanadan K, La Rosa S, et al. Intravesical Ty21a vaccine promotes dendritic cells and T cell-mediated
tumor regression in the MB49 bladder cancer model. Cancer Immunol Res 2019;7:621-9. DOI PubMed
107. Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res 2019;79:4557-66. DOI
PubMed PMC
108. Hou J, Karin M, Sun B. Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age? Nat Rev Clin
Oncol 2021;18:261-79. DOI PubMed PMC
109. Fu A, Yao B, Dong T, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell
2022;185:1356-72.e26. DOI
110. Pushalkar S, Hundeyin M, Daley D, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and
adaptive immune suppression. Cancer Discov 2018;8:403-16. DOI PubMed PMC